Term Name: EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor
Synonyms: aldehyde reductase 1 inhibitor, aldehyde reductase 1 inhibitors, ALR3 inhibitor, ALR3 inhibitors, carbonyl reductase (NADPH) (EC 1.1.1.184) inhibitor, carbonyl reductase (NADPH) (EC 1.1.1.184) inhibitors, carbonyl reductase (NADPH) inhibitor, carbonyl reductase (NADPH) inhibitors, carbonyl reductase (NADPH2) inhibitor, carbonyl reductase (NADPH2) inhibitors, carbonyl reductase inhibitor, carbonyl reductase inhibitors, EC 1.1.1.184 (carbonyl reductase (NADPH)) inhibitor, EC 1.1.1.184 (carbonyl reductase (NADPH)) inhibitors, EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitors, EC 1.1.1.184 inhibitor, EC 1.1.1.184 inhibitors, NADPH2-dependent carbonyl reductase inhibitor, NADPH2-dependent carbonyl reductase inhibitors, nonspecific NADPH-dependent carbonyl reductase inhibitor, nonspecific NADPH-dependent carbonyl reductase inhibitors, prostaglandin 9-ketoreductase inhibitor, prostaglandin 9-ketoreductase inhibitors, secondary-alcohol:NADP+ oxidoreductase inhibitor, secondary-alcohol:NADP+ oxidoreductase inhibitors, xenobiotic ketone reductase inhibitor, xenobiotic ketone reductase inhibitors
Definition: An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of carbonyl reductase (NADPH), EC 1.1.1.184.
Ontology: ChEBI [CHEBI:73136]  ( EBI )

Relationships
is a type of: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
inverse has_role: phenylbutazone quercitrin